Nicolas Lepareur
75
Documents
Publications
Publications
Design and evaluation of mono-N-functionalized pyclen for gallium-68 PET imaging6th SCIENTIFIC DAYS OF THE RESEARCH NETWORK ON MOLECULAR IMAGING AGENTS - GDR AIM, Oct 2024, Lyon, France
Communication dans un congrès
hal-05111602
v1
|
|
Study of radiolabeled hepatotropic peptide derivatives for the diagnosis and treatment of hepatocellular carcinoma15th Workshop New modalities in Cancer Imaging and Therapy, Oct 2022, Erquy, France. pp.S41-S41
Communication dans un congrès
hal-04011144
v1
|
|
Nanovectorized radiotherapy by convection-enhanced delivery (CED), a promising strategy that demonstrates high efficacy in a murine model of human endometrial adenocarcinomaDo.MoRe – 6th International Symposium on DOsimetry and MOlecular Radiotherapy during 28th Annual Congress of the European Association of Nuclear Medicine, Oct 2015, Hambourg, Germany
Communication dans un congrès
hal-02615970
v1
|
|
Développement d'un nouvel outil de radiothérapie interne dans le glioblastomeLe microbiote dans tous ses états. Journée de la SFR-ICAT 4208, 2015, Angers, France
Communication dans un congrès
hal-02615953
v1
|
|
Rhenium-188: application for glioblastoma internal radiotherapy8th International Symposium on Technetium and Rhenium: Science and Utilization, 2014, Pornichet, France
Communication dans un congrès
hal-03180808
v1
|
|
Starch based microparticles radiolabelling with 99mTc and 188Re for diagnostic and therapy of Hepatocellular carcinoma8th International Symposium on Technetium and Rhenium: Science and Utilization, 2014, Pornichet, France
Communication dans un congrès
hal-03180807
v1
|
|
Mise au point de nouvelles formulations lipiodolées de viscosité augmentée en vue de l'optimisation du ciblage de l'hépatocarcinome.49ème colloque de médecine nucléaire de langue française, May 2011, Luxembourg
Communication dans un congrès
hal-00674903
v1
|
|
Nanovectorized internal radiation therapy in a glioblastoma rat modelEAMN'10 : 23th Annual Congress of the European Association of Nuclear Medicine, 2010, Vienna, Austria. pp.S281
Communication dans un congrès
hal-03180803
v1
|
|
Evaluation OF Immune Responses after Nanovectorized Internal Radiotherapy for GlioblastomasWorld Molecular Imaging Congress (WMIC), 2010, Kyoto, Japan
Communication dans un congrès
hal-03180827
v1
|
|
Evaluation of immune responses after nanovectorized internal radiotherapy for glioblastomas4th European Workshop on Biology of ionizing radiation, 2010, Larmor-Baden, France
Communication dans un congrès
hal-03180832
v1
|
|
Fractionated internal radiation with stereotaxic injection of 188Re-loaded lipid nanocapsules in a rat glioblastoma model56th Annual meeting of the Society of Nuclear Medicine, 2009, Toronto, Canada
Communication dans un congrès
hal-03180845
v1
|
|
Développement d'un marquage du lipiodol au 99mTc et étude de biodistribution sur le porc sain41. Colloque, 2003, Tours, France
Communication dans un congrès
hal-02829415
v1
|
Composition for therapeutic use, including an organic lipid phase and a rare- earth radioisotope complexPatent n° : WO 2014012997. 2014, pp.25
Brevet
hal-00936709
v1
|
|
Therapeutic composition including an organic lipid phase and a complex of a rare earth radioisotopePatent n° : FR 2993462. 2014, pp.20
Brevet
hal-00936718
v1
|
|
|
VECTORISATIONS ACTIVE ET PASSIVE DE RADIOPHARMACEUTIQUES DU TECHNETIUM-99m ET DU RHENIUM-188 POUR L'IMAGERIE MEDICALE ET LA THERAPIEAutre. Université Rennes 1; Università degli studi di Ferrara, 2003. Français. ⟨NNT : ⟩
Thèse
tel-00128645
v1
|
Chargement...
Chargement...